DPhil Study Day Logo

This year’s 14th Annual Medical Sciences DPhil Day, a student-organised symposium, proudly showcased the varied and excellent biomedical and clinical research carried out by DPhil students across the Medical Sciences Division.

The event gave students the opportunity to present to their peers and see an exciting cross-section of ongoing research at Oxford’s many research sites.

3.JPG

Over 100 attendees attended 15 student talks covering a wide breadth of topics including neuroscience, organ transplantation, structural biology and vaccine design. Prizes were awarded to Malte Kaller (1st) and Janine Grey (2nd) for their outstanding presentations on myelination and drug development and active audience involvement was recognised with a prize for the best audience question awarded to Lancelot Millar. Students were also given the opportunity to present their posters with prizes awarded to Layal Liverpool (1st) and Amy Flaxman (2nd) for their work on host-viral interactions and microbiomes, respectively.

5.JPG

In addition to student presentations, Naomi Gibson, MSD Public Engagement Coordinator, spoke to students on the topic of Public Engagement, its increasing importance and how students can become involved as an integral part of their research careers.

The keynote lecture was provided by Professor Eleanor Riley of The London School of Hygiene and Tropical Medicine. Soon to take up a new post as Director of the Roslin Institute at Edinburgh University, we would like to thank Professor Riley for taking time travel to Oxford and share her insights from a long and inspiring career in multidisciplinary infectious disease research and malaria immunology.

2.JPG

The organising committee would also like to extend their thanks to Jane Rudman, Professor Afsie Sabokbar, Veliborka Milivojevic, our sponsors*, and to all the students who attended and presented their research for making the event a great success.

If you are interested in joining the organising committee for the 2018 event, please contact us or Jane Rudman for more information.

DPhil Day 2017 Committee

Agata Antepowicz, Alice Stelfox, Kento Kawai, Francesca Donnellan and Norbert Volkmar

 

Our sponsors

*Gilson, MACS Miltenyi Biotec, PeproTech, Sarstedt, Triplered

Similar stories

UK and EU regulators conclude benefits of vaccination continue to outweigh the risks

Coronavirus COVID-19 General

Today, the medical regulators in the UK and Europe have announced their conclusions from their reviews of very rare cases of unusual blood clots in people who have received the Oxford-AstraZeneca coronavirus vaccine.

Link between COVID-19 infection and subsequent mental health and neurological conditions found

Coronavirus COVID-19 General Research

One in three COVID-19 survivors received a neurological or psychiatric diagnosis within six months of infection with the SARS-CoV-2 virus, an observational study of more than 230,000 patient health records published in The Lancet Psychiatry journal estimates. The study looked at 14 neurological and mental health disorders.

New national study of long-term impacts of debilitating lung damage from COVID-19

Coronavirus COVID-19 General Research

A new national study will investigate the long-term effects of lung inflammation and scarring from COVID-19. The study, launched with £2 million of funding from UK Research and Innovation (UKRI), aims to develop treatment strategies and prevent disability.

Opportunities for final goodbyes must be prioritised in COVID-19 pandemic

Coronavirus COVID-19 General Research

Bereaved relatives described the ongoing pain of being absent at the end of a loved-one's life. Many had not seen their relative for weeks or months due to the pandemic. Opportunities must be prioritised for essential connections between families at end-of-life care.

New study shows overwhelming public support for donating vaccines to low-income countries

Coronavirus COVID-19 General Research

A survey led by Nuffield Department of Population Health's Health Economics Research Centre has found that most people in high-income countries support donating some of their country’s COVID-19 vaccine supplies to low-income nations who would otherwise struggle to gain access.